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Abstracts / Journal of Nutrition & Intermediary Metabolism 1 (2014) 1e55 31intakes of fruits, vegetables, whole-grains, dairy and dairy components, cal-
cium, vitamin D, whey protein, as well as monounsaturated and n-3 fatty
acids.
Conclusions: There was a paucity of information on potential beneﬁts of
traditional dietary patterns from the Asia-Paciﬁc region. Future research
based onwell-designed RCTs or prospective trials could extend the value of
such dietary patterns to other regions of the world.
Funding source(s): N/A.
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Background/Aims: To compare the efﬁcacy of the palaeolithic diet and the
AGHE in terms of metabolic and cardiovascular risk factors and body
composition over a 4-week dietary intervention.
Methods: Thirty nine healthywomen (mean ± SD age 47± 13 y and BMI 27
± 4 kg/m2), were randomised to an ad libitum palaeolithic (n¼ 22) or AGHE
(n ¼ 17) diet for 4 weeks. A 3-day weighed food record (WFR), and blood
and urine samples were collected pre- and post-intervention. Within and
between group analyses were performed using paired t-tests or Mann-
Whitney and independent t-tests, respectively.
Results: Weight loss occurred in both groups, with signiﬁcantly greater loss
(-3.2±1kg vs. -1.2±1kg,p<0.001) and reduction inwaist circumference (3.3
±2cmvs.1.5±2cm,p<0.05) in thepalaeolithic group.A7-9%meanreduction
in total and LDL-cholesterol was observed in both groups with no difference
between groups. Red cell folate (980± 300 vs. 751± 149nmol/L, p< 0.05) and
plasma b-carotene (2.41 ± 2 vs. 1.62 ± 1 mmol/L, p < 0.05) were signiﬁcantly
higher in the palaeolithic group, indicative of the increased fruit and vegetable
consumption. There were no changes in a-carotene or lycopene, or in blood
pressure, fasting insulin, glucose or C-reactive protein in either group.
Conclusions: The palaeolithic diet induced favourable changes in body
composition over a short-term intervention period. The efﬁcacy of the diet
was comparable to other dietary patterns that reduce cardiovascular risk
factors, however further studies are required to assess longer term health
impacts and feasibility of the palaeolithic diet.
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Background/Aims: Dietary supplementationwith n-3PUFA has been shown
to retard atherogenic process, partly via improvements in lipoprotein proﬁle.
The objective of this studywas to evaluate any association between n-3PUFA
status and blood lipid levels in a group of older Australians.
Methods: Men (n ¼ 271) and women (n ¼ 349) aged 65-95 years living in
the Central Coast Region of NSW were recruited. Fasting blood samples
were analysed for total cholesterol (TC), TAG, HDL- and LDL-cholesterol. n-
3PUFA status (%EPA plus %DHA) was determined from the fatty acid
composition of erythrocyte membranes analysed by GC.
Results: n-3PUFA statuswas positively associatedwith plasma TC (r¼ 0.082,
p < 0.05), LDL-cholesterol (r ¼ 0.088, p < 0.05) and HDL-cholesterol (r ¼
0.163, p < 0.001), and negatively correlated with plasma TAG (r ¼ -0.217, p <
0.001) levels. The association between n-3PUFA status and plasma TAG was
stronger in females (r ¼ -0.279, p < 0.001) than males (r ¼ -0.141, p < 0.05)
and the association between n-3PUFA status and HDL-cholesterol was
evident in females only (r ¼ 0.177, p < 0.001). The relationship between n-
3PUFA status and TC or LDL-cholesterol levels was not signiﬁcant whenparticipants were stratiﬁed on gender. However, the correlation coefﬁcient
was larger and approached signiﬁcance in the female group.
Conclusions: In this study n-3PUFA status was associated with an anti-
atherogenic blood lipid proﬁle in an older, high risk population in a sex-
dependent manner. These ﬁndings support the development and imple-
mentation of dietary strategies designed to reduce the risk of cardiovas-
cular disease by improving n-3PUFA status.
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Background/Aims: The association between n-3PUFA status and risk of
T2DM remains unclear. We have recently demonstrated a negative asso-
ciation between erythrocyte n-3PUFA levels and insulin resistance in obese
children. This study was to determine whether n-3PUFA status is associ-
ated with T2DM in high risk older Australians.
Methods: A cross-sectional sample of older adults aged 65-95 years (n ¼
620) from the Central Coast Region, NSWwere recruited. Diabetic statuswas
determined according toWorld Health Organisation criteria. n-3PUFA status
(%EPA plus %DHA) was determined by analysing the fatty acid composition
of erythrocyte membranes by GC. Fasting blood sugar (BGL), insulin and
HbA1c levels were measured by a commercial pathology service.
Results: Following application of exclusion criteria, 96 T2DM (females 42.7%;
mean±SDage76.6±6.0years) and512non-T2DM(females58.6%; age77.8±
7.1 years) participants were included in the analysis. Erythrocyte n-3PUFA
levelswere signiﬁcantly lower inT2DMthannon-T2DMsubjects (8.03±2.0%
vs. 8.57 ± 2.3%; p¼ 0.03).When participants were stratiﬁed by BMI, weight-
dependentdifferenceswere evidentwithoverweight/obese ( 27kg/m2)but
not healthy/lowweight (< 27 kg/m2) subjects showing a negative correlation
between n-3PUFA status and T2DM (Goodman-Kruskal’s g ¼ -0.267; p <
0.01). An inverse relationship betweenn-3PUFA status andboth fasting BSL (r
¼ -0.115; p ¼ 0.02) and HbA1c (r ¼ -0.115; p ¼ 0.03) was also detected in
overweight/obese but not healthy/low weight participants. No association
was found between n-3PUFA status and fasting insulin levels.
Conclusions: This is the ﬁrst study to demonstrate a weight-dependent in-
verse relationshipbetween long-termn-3PUFA status andT2D inolderadults.
Funding source(s): ARC.
REPETITIVE GUT CHALLENGE REDUCES GASTRO-INTESTINAL
SYMPTOMS AND MALABSORPTION OF CARBOHYDRATES DURING
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Background/Aims: The study aimed to determine if commonly reported
and debilitating gastrointestinal symptoms (GIS) and carbohydrate
malabsorption during exertional stress is altered by daily gut-challenge
over two weeks.
Methods: Healthy endurance trained participants performed an initial
gut-challenge trial (GC1) comprising 2 hours of running at 60% VO2max
whilst consuming 30 g carbohydrates (2:1 glucose-fructose, 10% weight:-
volume) every 20 mins, followed by a 1 hour time trial. GIS were moni-
tored every 10 mins during exercise using a 10 cm rating scale. Breath
samples were collected every hour during exercise and recovery, and
analysed via a Breathtracker Digital Microlyzer. After 10-days’ gut training
protocol comprising of 1 hour of running at 60% VO2max whilst consuming
30 g carbohydrate (2:1 glucose-fructose, 10% weight:volume) every 20
